Ovarian Cancers

Oncology·MeSH: Ovarian Neoplasms

Prevalence

24.0 / 100K

Incidence

10.6 / 100K/yr

4 drugs in development·3 companies·1 clinical trial

Drug Pipeline by Phase

Compare drugs

emi-le vs AMHR2-ED ovarian cancer vaccineemi-le vs Ovarian cancer vaccine (AMHR2-ED)emi-le vs SNAP-CAR Platform

Frequently asked questions

How many drugs are in development for Ovarian Cancers?

BioSniper tracks 4 drugs in development for Ovarian Cancers across 3 companies.

How many clinical trials target Ovarian Cancers?

There are 1 clinical trial targeting Ovarian Cancers tracked by BioSniper.

What is the prevalence of Ovarian Cancers?

The estimated prevalence of Ovarian Cancers is approximately 24.0 per 100,000 population.

Deep-dive into Ovarian Cancers

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Ovarian Cancers — Drugs in Development & Clinical Trials | BioSniper